⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
globenewswire.com
IBIO
Form 8-K
sec.gov
IBIO
SHINE Completes $240 Million in Recent Funding Led by Dr. Patrick Soon-Shiong, Founder of NantWorks, Who Joins Board of Directors
prnewswire.com
IBIO
IntraBio Receives Positive European Medicines Agency Opinion for Orphan Medicinal Product Designation for Acetylleucine for CACNA1A Disorders
businesswire.com
IBIO
iBio to Participate in Upcoming Investor Conferences
globenewswire.com
IBIO
Integrated Biosciences Appoints Tony Wu, Co-Founder of xAI, to its Scientific Advisory Board
businesswire.com
IBIO
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
FATE
INDP
AMGN
NKTR
IBIO
TAK
SNY
INMB
CLMT
VERX
GTBP
BHVN
CHRS
GSK
BMY
MRK
ABBV
AZN
GILD
LLY
KYMR
REGN
SPRY
Dr. Emil Lou, Intima Bioscience Principal Investigator, Named to 2026 TIME100 Health List
prnewswire.com
IBIO
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
businesswire.com
IBIO
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
globenewswire.com
IBIO